Final Q-Sub Guidance Describes FDA Meeting Policy

A new final guidance document from the US FDA explains how the agency wants device developers to use its Q-Submission Program to get agency feedback outside the formal product submission process.

Group of business people having a late night video conference meeting. Sitting around a conference table talking and networking. - Image

More from Regulation

More from Policy & Regulation